Q32 Bio Inc. Share Price
QTTBQ32 Bio Inc. Stock Performance
Open $3.51 | Prev. Close $3.57 | Circuit Range N/A |
Day Range $3.40 - $3.60 | Year Range $1.34 - $6.31 | Volume 2,025 |
Average Traded $3.57 |
Q32 Bio Inc. Share Price Chart
About Q32 Bio Inc.
Q32 Bio Inc., a clinical-stage biotechnology company, develops novel biologics to restore healthy immune balance in patients with autoimmune and inflammatory diseases driven by pathological immune dysfunction. The company is developing Bempikibart (ADX-914), a fully human antiinterleukin-7 receptor alpha antagonist monoclonal antibody designed to re-regulate adaptive immune function by blocking signaling mediated by interleukin-7 and thymic stromal lymphopoietin for the treatment of atopic dermatitis and alopecia areata. It also develops ADX-096, a C3d mAb CR1 fusion protein for use in ophthalmologic indications, as well as other C3d mAb fusions and nanobodies designed for tissue-targeted complement inhibition. The company was founded in 2017 and is based in Waltham, Massachusetts.
Q32 Bio Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
16-Jan-26 | $3.51 | $3.61 | +0.28% |
15-Jan-26 | $3.54 | $3.60 | +0.14% |
14-Jan-26 | $3.42 | $3.60 | +5.74% |
13-Jan-26 | $3.54 | $3.40 | -7.23% |
12-Jan-26 | $3.68 | $3.67 | +1.24% |
09-Jan-26 | $3.65 | $3.62 | -0.28% |
08-Jan-26 | $3.33 | $3.63 | +10.67% |